Endothelial progenitor cell-based therapy for pulmonary arterial hypertension

Cell Transplantation

Volumn 22, Issue 8, 2013, Pages 1325-1336

  Yang, Jin Xiu ^a   Pan, Yan Yun ^a   Zhao, You Yang ^b   Wang, Xing Xiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Endothelial progenitor cells (EPCs); Mechanisms; Pulmonary arterial hypertension (PAH); Transplantation

Indexed keywords

ADRENOMEDULLIN; CD133 ANTIGEN; CD34 ANTIGEN; CILOSTAZOL; FIBRONECTIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; PLACENTAL GROWTH FACTOR; SCATTER FACTOR; SILDENAFIL; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL BEHAVIOR; APOPTOSIS; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; COLONY FORMING UNIT; CYTOKINE RELEASE; DISEASE COURSE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIAL PROGENITOR CELL TRANSPLANTATION; ENGRAFTMENT; EXERCISE; GENE TRANSFER; HUMAN; LUNG HEMODYNAMICS; MICROENVIRONMENT; NEOINTIMA; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REVIEW; SHEAR STRESS; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

ANIMALIA;

EID: 85047687247     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X659899     Document Type: Review

References (98)

1. Arciniegas, E.; Neves, C. Y.; Carrillo, L. M.; Zambrano, E. A.; Ramirez, R. Endothelial-mesenchymal transition occurs during embryonic pulmonary artery development. Endothelium 12(4):193-200; 2005.
2. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J. M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964-967; 1997.
3. Asahara, T.; Takahashi, T.; Masuda, H.; Kalka, C.; Chen, D.; Iwaguro, H.; Inai, Y.; Silver, M.; Isner, J. M. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18(14):3964-3972; 1999.
4. Asosingh, K.; Aldred, M. A.; Vasanji, A.; Drazba, J.; Sharp, J.; Farver, C.; Comhair, S. A.; Xu, W.; Licina, L.; Huang, L.; Anand-Apte, B.; Yoder, M. C.; Tuder, R. M.; Erzurum, S. C. Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension. Am. J. Pathol. 172(3):615-627; 2008.
5. Barst, R. Is it possible to reverse the endothelial dysfunction in pulmonary arterial hypertension? J. Am. Coll. Cardiol. 49(14):1572-1574; 2007.
6. Budhiraja, R.; Tuder, R. M.; Hassoun, P. M. Endothelial dysfunction in pulmonary hypertension. Circulation 109(2): 159-165; 2004.
7. Campbell, A. I.; Zhao, Y.; Sandhu, R.; Stewart, D. J. Cellbased gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 104(18):2242-2248; 2001.
8. + cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp. Hematol. 35(7):1109- 1118; 2007.
9. Chan, S. Y.; Loscalzo, J. Pathogenic mechanisms of pulmonary arterial hypertension. J. Mol. Cell. Cardiol. 44(1): 14-30; 2008.
10. Cho, H. J.; Lee, N.; Lee, J. Y.; Choi, Y. J.; Ii, M.; Wecker, A.; Jeong, J. O.; Curry, C.; Qin, G.; Yoon, Y. S. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J. Exp. Med. 204(13):3257-3269; 2007.
11. Cowan, K. N.; Jones, P. L.; Rabinovitch, M. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J. Clin. Invest. 105(1):21-34; 2000.
12. Davie, N. J.; Crossno, J. T,Jr.; Frid, M. G.; Hofmeister, S. E.; Reeves, J. T.; Hyde, D. M.; Carpenter, T. C.; Brunetti, J. A.; McNiece, I. K.; Stenmark, K. R,Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: Contribution of progenitor cells. Am. J. Physiol. Lung Cell Mol. Physiol. 286(4):L668-678; 2004.
13. Desmouliere, A.; Chaponnier, C.; Gabbiani, G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 13(1):7-12; 2005.
14. Diller, G. P.; Thum, T.; Wilkins, M. R.; Wharton, J. Endothelial progenitor cells in pulmonary arterial hypertension. Trends Cardiovasc. Med. 20(1):22-29; 2010.
15. Diller, G. P.; van Eijl, S.; Okonko, D. O.; Howard, L. S.; Ali, O.; Thum, T.; Wort, S. J.; Bedard, E.; Gibbs, J. S.; Bauersachs, J.; Hobbs, A. J.; Wilkins, M. R.; Gatzoulis, M. A.; Wharton, J. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation 117(23): 3020-3030; 2008.
16. Ding, D. C.; Shyu, W. C.; Lin, S. Z.; Li, H. The role of endothelial progenitor cells in ischemic cerebral and heart diseases. Cell Transplant. 16(3):273-284; 2007.
17. Di Santo, S.; Yang, Z.; Wyler von Ballmoos, M.; Voelzmann, J.; Diehm, N.; Baumgartner, I.; Kalka, C. Novel cell-free strategy for therapeutic angiogenesis: In vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One 4(5):e5643; 2009.
18. Fadini, G. P.; Schiavon, M.; Rea, F.; Avogaro, A.; Agostini, C. Depletion of endothelial progenitor cells may link pulmonary fibrosis and pulmonary hypertension. Am. J. Respir. Crit. Care Med. 176(7):724-725; 2007.
19. Frid, M. G.; Brunetti, J. A.; Burke, D. L.; Carpenter, T. C.; Davie, N. J.; Reeves, J. T.; Roedersheimer, M. T.; van Rooijen, N.; Stenmark, K. R. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am. J. Pathol. 168(2):659-669; 2006.
20. Fujiyama, S.; Amano, K.; Uehira, K.; Yoshida, M.; Nishiwaki, Y.; Nozawa, Y.; Jin, D.; Takai, S.; Miyazaki, M.; Egashira, K.; Imada, T.; Iwasaka, T.; Matsubara, H. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ. Res. 93(10):980-989; 2003.
21. Gabbiani, G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200(4):500-503; 2003.
22. Ghofrani, H. A.; Barst, R. J.; Benza, R. L.; Champion, H. C.; Fagan, K. A.; Grimminger, F.; Humbert, M.; Simonneau, G.; Stewart, D. J.; Ventura, C.; Rubin, L. J. Future perspectives for the treatment of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 54(1 Suppl):S108-117; 2009.
23. Gnecchi, M.; Zhang, Z.; Ni, A.; Dzau, V. J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103(11):1204-1219; 2008.
24. Gulati, R.; Jevremovic, D.; Peterson, T. E.; Chatterjee, S.; Shah, V.; Vile, R. G.; Simari, R. D. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. 93(11):1023-1025; 2003.
25. Gulati, R.; Jevremovic, D.; Peterson, T. E.; Witt, T. A.; Kleppe, L. S.; Mueske, C. S.; Lerman, A.; Vile, R. G.; Simari, R. D. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 108(12):1520-1526; 2003.
26. - blood-derived human endothelial cell progenitors. Stem Cells 19(4):304-312; 2001.
27. Hayashida, K.; Fujita, J.; Miyake, Y.; Kawada, H.; Ando, K.; Ogawa, S.; Fukuda, K. Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxiainduced pulmonary hypertension. Chest 127(5):1793- 1798; 2005.
28. Hill, J. M.; Zalos, G.; Halcox, J. P.; Schenke, W. H.; Waclawiw, M. A.; Quyyumi, A. A.; Finkel, T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348(7):593-600; 2003.
29. Hristov, M.; Weber, C. Endothelial progenitor cells: Characterization, pathophysiology, and possible clinical relevance. J. Cell. Mol. Med. 8(4):498-508; 2004.
30. Humbert, M.; Sitbon, O.; Simonneau, G. Treatment of pulmonary arterial hypertension. N. Engl. J. Med. 351(14):1425-1436; 2004.
31. Hur, J.; Yoon, C. H.; Kim, H. S.; Choi, J. H.; Kang, H. J.; Hwang, K. K.; Oh, B. H.; Lee, M. M.; Park, Y. B. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24(2):288-293; 2004.
32. Ihida-Stansbury, K.; McKean, D. M.; Lane, K. B.; Loyd, J. E.; Wheeler, L. A.; Morrell, N. W.; Jones, P. L. Tenascin-C is induced by mutated BMP type 2 receptors in familial forms of pulmonary arterial hypertension. Am. J. Physiol. Lung Cell Mol. Physiol. 291(4):L694-L702; 2006.
33. Junhui, Z.; Xingxiang, W.; Guosheng, F.; Yunpeng, S.; Furong, Z.; Junzhu, C. Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension. Respir. Med. 102(7):1073-1079; 2008.
34. Jurasz, P.; Courtman, D.; Babaie, S.; Stewart, D. J. Role of apoptosis in pulmonary hypertension: From experimental models to clinical trials, Pharmacol. Ther. 126(1):1-8; 2010.
35. Lin, R. Z.; Dreyzin, A.; Aamodt, K.; Dudley, A. C.; Melero Martin, J. M. Functional endothelial progenitor cells from cryopreserved umbilical cord blood. Cell Transplant. 20(4): 515-522; 2011.
36. Lin, Y.; Weisdorf, D. J.; Solovey, A.; Hebbel, R. P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105(1):71-77; 2000.
37. Mai, X. L.; Ma, Z. L.; Sun, J. H.; Ju, S. H.; Ma, M.; Teng, G. J. Assessments of proliferation capacity and viability of New Zealand rabbit peripheral blood endothelial progenitor cells labeled with superparamagnetic particles. Cell Transplant. 18(2):171-181; 2009.
38. Marsboom, G.; Janssens, S. Endothelial progenitor cells: New perspectives and applications in cardiovascular therapies. Expert. Rev. Cardiovasc. Ther. 6(5):687-701; 2008.
39. Marsboom, G.; Pokreisz, P.; Gheysens, O.; Vermeersch, P.; Gillijns, H.; Pellens, M.; Liu, X.; Collen, D.; Janssens, S. Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension. Stem Cells 26(4):1017-1026; 2008.
40. Masri, F. A.; Xu, W.; Comhair, S. A.; Asosingh, K.; Koo, M.; Vasanji, A.; Drazba, J.; Anand-Apte, B.; Erzurum, S. C. Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am. J. Physiol. Lung Cell Mol. Physiol. 293(3):L548-L554; 2007.
41. McMurtry, M. S.; Archer, S. L.; Altieri, D. C.; Bonnet, S.; Haromy, A.; Harry, G.; Puttagunta, L.; Michelakis, E. D. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J. Clin. Invest. 115(6):1479-1491; 2005.
42. Medina, R. J.; O'Neill, C. L.; Sweeney, M.; Guduric-Fuchs, J.; Gardiner, T. A.; Simpson, D. A.; Stitt, A. W. Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med. Genomics 3:18; 2010.
43. Meyrick, B.; Reid, L. Hypoxia and incorporation of 3Hthymidine by cells of the rat pulmonary arteries and alveolar wall. Am. J. Pathol. 96(1):51-70; 1979.
44. Meyrick, B. O.; Reid, L. M. Crotalaria-induced pulmonary hypertension. Uptake of 3H-thymidine by the cells of the pulmonary circulation and alveolar walls. Am. J. Pathol. 106(1):84-94; 1982.
45. Miller-Kasprzak, E.; Jagodzinski, P. P. Endothelial progenitor cells as a new agent contributing to vascular repair. Arch. Immunol. Ther. Exp. 55(4):247-259; 2007.
46. Mirsky, R.; Jahn, S.; Koskenvuo, J. W.; Sievers, R. E.; Yim, S. M.; Ritner, C.; Bernstein, H. S.; Angeli, F. S.; Boyle, A. J.; De Marco, T.; Yeghiazarians, Y. Treatment of Pulmonary Arterial Hypertension with Circulating Angiogenic Cells. Am. J. Physiol. Lung Cell Mol. Physiol. 301(1):L12-L19; 2011.
47. Morrell, N. W.; Adnot, S.; Archer, S. L.; Dupuis, J.; Jones, P. L.; MacLean, M. R.; McMurtry, I. F.; Stenmark, K. R.; Thistlethwaite, P. A.; Weissmann, N.; Yuan, J. X.; Weir, E. K. Cellular and molecular basis of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 54(1 Suppl):S20-S31; 2009.
48. Nagaya, N.; Kangawa, K.; Kanda, M.; Uematsu, M.; Horio, T.; Fukuyama, N.; Hino, J.; Harada-Shiba, M.; Okumura, H.; Tabata, Y.; Mochizuki, N.; Chiba, Y.; Nishioka, K.; Miyatake, K.; Asahara, T.; Hara, H.; Mori, H. Hybrid cellgene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 108(7):889-895; 2003.
49. Ormiston, M. L.; Deng, Y.; Stewart, D. J.; Courtman, D. W. Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 43(5):546-554; 2010.
50. Patel, A. N.; Sherman, W. Cardiac stem cell therapy: Advances from 2008. Cell Transplant. 18(3):243-244; 2009.
51. Peichev, M.; Naiyer, A. J.; Pereira, D.; Zhu, Z.; Lane, W. J.; Williams, M.; Oz, M. C.; Hicklin, D. J.; Witte, L.; Moore, M. A.; Rafii, S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95(3):952-958; 2000.
52. Prater, D. N.; Case, J.; Ingram, D. A.; Yoder, M. C. Working hypothesis to redefine endothelial progenitor cells. Leukemia 21(6):1141-1149; 2007.
53. Raoul, W.; Wagner-Ballon, O.; Saber, G.; Hulin, A.; Marcos, E.; Giraudier, S.; Vainchenker, W.; Adnot, S.; Eddahibi, S.; Maitre, B. Effects of bone marrow-derived cells on monocrotalineand hypoxia-induced pulmonary hypertension in mice. Respir. Res. 8:8; 2007.
54. Rehman, J. Feeling the elephant of cardiovascular cell therapy. Circulation 121(2):197-199; 2010.
55. Rehman, J.; Li, J.; Orschell, C. M.; March, K. L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107(8):1164-1169; 2003.
56. Rhodes, C. J.; Davidson, A.; Gibbs, J. S.; Wharton, J.; Wilkins, M. R. Therapeutic targets in pulmonary arterial hypertension. Pharmacol. Ther. 121(1):69-88; 2009.
57. Richardson, M. R.; Yoder, M. C. Endothelial progenitor cells: Quo vadis? J. Mol. Cell. Cardiol. 50(2):266-272; 2011.
58. Roberts, K. E.; Barst, R. J.; McElroy, J. J.; Widlitz, A.; Chada, K.; Knowles, J. A.; Morse, J. H. Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension: Association with thyroid disease. Chest 128(6 Suppl):618S; 2005.
59. Rosenzweig, E. B.; Barst, R. J. Pulmonary arterial hypertension in children: A medical update. Curr. Opin. Pediatr. 20(3):288-293; 2008.
60. Rosenzweig, E. B.; Morse, J. H.; Knowles, J. A.; Chada, K. K.; Khan, A. M.; Roberts, K. E.; McElroy, J. J.; Juskiw, N. K.; Mallory, N. C.; Rich, S.; Diamond, B.; Barst, R. J. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. J. Heart Lung Transplant. 27(6):668- 674; 2008.
61. Runo, J. R.; Loyd, J. E. Primary pulmonary hypertension. Lancet 361(9368):1533-1544; 2003.
62. Sanchez, O.; Marcos, E.; Perros, F.; Fadel, E.; Tu, L.; Humbert, M.; Dartevelle, P.; Simonneau, G.; Adnot, S.; Eddahibi, S. Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 176(10):1041-1047; 2007.
63. Santhanam, A. V.; Smith, L. A.; He, T.; Nath, K. A.; Katusic, Z. S. Endothelial progenitor cells stimulate cerebrovascular production of prostacyclin by paracrine activation of cyclooxygenase-2. Circ. Res. 100(9):1379- 1388; 2007.
64. Schmidt-Lucke, C.; Rossig, L.; Fichtlscherer, S.; Vasa, M.; Britten, M.; Kamper, U.; Dimmeler, S.; Zeiher, A. M. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 111(22):2981-2987; 2005.
65. Sieveking, D. P.; Buckle, A.; Celermajer, D. S.; Ng, M. K. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: Insights from a novel human angiogenesis assay. J. Am. Coll. Cardiol. 51(6): 660-668; 2008.
66. Simonneau, G.; Robbins, I. M.; Beghetti, M.; Channick, R. N.; Delcroix, M.; Denton, C. P.; Elliott, C. G.; Gaine, S. P.; Gladwin, M. T.; Jing, Z. C.; Krowka, M. J.; Langleben, D.; Nakanishi, N.; Souza, R. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 54(1 Suppl):S43-S54; 2009.
67. Smadja, D. M.; Mauge, L.; Sanchez, O.; Silvestre, J. S.; Guerin, C.; Godier, A.; Henno, P.; Gaussem, P.; IsraelBiet, D. Distinct patterns of circulating endothelial cells in pulmonary hypertension. Eur. Respir. J. 36(6):1284- 1293; 2010.
68. Stenmark, K. R.; Davie, N.; Frid, M.; Gerasimovskaya, E.; Das, M. Role of the adventitia in pulmonary vascular remodeling. Physiology 21:134-145; 2006.
69. Stenmark, K. R.; Fagan, K. A.; Frid, M. G. Hypoxia-induced pulmonary vascular remodeling: Cellular and molecular mechanisms. Circ. Res. 99(7):675-691; 2006.
70. Sun, C. K.; Lee, F. Y.; Sheu, J. J.; Yuen, C. M.; Chua, S.; Chung, S. Y.; Chai, H. T.; Chen, Y. T.; Kao, Y. H.; Chang, L. T.; Yip, H. K. Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats. J. Pharmacol. Exp. Ther. 330(3):718-726; 2009.
71. Sun, C. K.; Lin, Y. C.; Yuen, C. M.; Chua, S.; Chang, L. T.; Sheu, J. J.; Lee, F. Y.; Fu, M.; Leu, S.; Yip, H. K. Enhanced protection against pulmonary hypertension with sildenafil and endothelial progenitor cell in rats. Int. J. Cardiol. 162:45-58; 2012.
72. Takahashi, M.; Nakamura, T.; Toba, T.; Kajiwara, N.; Kato, H.; Shimizu, Y. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng. 10(5-6):771-779; 2004.
73. Teichert-Kuliszewska, K.; Kutryk, M. J.; Kuliszewski, M. A.; Karoubi, G.; Courtman, D. W.; Zucco, L.; Granton, J.; Stewart, D. J. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: Implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ. Res. 98(2):209-217; 2006.
74. Timmermans, F.; Plum, J.; Yoder, M. C.; Ingram, D. A.; Vandekerckhove, B.; Case, J. Endothelial progenitor cells: Identity defined? J. Cell. Mol. Med. 13(1):87-102; 2009.
75. + hematopoietic precursors. Arterioscler. Thromb. Vasc. Biol. 27(7):1572-1579; 2007.
76. Tomasek, J. J.; Vaughan, M. B.; Kropp, B. P.; Gabbiani, G.; Martin, M. D.; Haaksma, C. J.; Hinz, B. Contraction of myofibroblasts in granulation tissue is dependent on Rho/ Rho kinase/myosin light chain phosphatase activity. Wound Repair Regen. 14(3):313-320; 2006.
77. Toshner, M.; Voswinckel, R.; Southwood, M.; Al-Lamki, R.; Howard, L. S.; Marchesan, D.; Yang, J.; Suntharalingam, J.; Soon, E.; Exley, A.; Stewart, S.; Hecker, M.; Zhu, Z.; Gehling, U.; Seeger, W.; Pepke-Zaba, J.; Morrell, N. W. Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 180(8):780-787; 2009.
78. Tuder, R. M.; Chacon, M.; Alger, L.; Wang, J.; Taraseviciene Stewart, L.; Kasahara, Y.; Cool, C. D.; Bishop, A. E.; Geraci, M.; Semenza, G. L.; Yacoub, M.; Polak, J. M.; Voelkel, N. F. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: Evidence for a process of disordered angiogenesis. J. Pathol. 195(3):367-374; 2001.
79. Tuder, R. M.; Cool, C. D.; Yeager, M.; Taraseviciene Stewart, L.; Bull, T. M.; Voelkel, N. F. The pathobiology of pulmonary hypertension. Endothelium Clin. Chest Med. 22(3):405-418; 2001.
80. Tuder, R. M.; Marecki, J. C.; Richter, A.; Fijalkowska, I.; Flores, S. Pathology of pulmonary hypertension. Clin. Chest. Med. 28(1):23-42; 2007.
81. Tuder, R. M.; Yeager, M. E.; Geraci, M.; Golpon, H. A.; Voelkel, N. F. Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene. Eur. Respir. J. 17(6):1065-1069; 2001.
82. Urbich, C.; Aicher, A.; Heeschen, C.; Dernbach, E.; Hofmann, W. K.; Zeiher, A. M.; Dimmeler, S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 39(5):733-742; 2005.
83. Urbich, C.; Dimmeler, S. Endothelial progenitor cells: Characterization and role in vascular biology. Circ. Res. 95(4):343-353; 2004.
84. + and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110(10):1209-1212; 2004.
85. Vanneaux, V.; El-Ayoubi, F.; Delmau, C.; Driancourt, C.; Lecourt, S.; Grelier, A.; Cras, A.; Cuccuini, W.; Soulier, J.; Lataillade, J. J.; Lebousse-Kerdiles, M. C.; Oury, J. F.; Sibony, O.; Marolleau, J. P.; Benbunan, M.; Uzan, G.; Larghero, J,In vitro and in vivo analysis of endothelial progenitor cells from cryopreserved umbilical cord blood: Are we ready for clinical application? Cell Transplant. 19(9):1143-1155; 2010.
86. Voelkel, N. F.; Cool, C.; Taraceviene-Stewart, L.; Geraci, M. W.; Yeager, M.; Bull, T.; Kasper, M.; Tuder, R. M. Janus face of vascular endothelial growth factor: The obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension. Crit. Care Med. 30(5 Suppl):S251-S256; 2002.
87. Wang, X. X.; Zhang, F. R.; Shang, Y. P.; Zhu, J. H.; Xie, X. D.; Tao, Q. M.; Chen, J. Z. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: A pilot randomized controlled trial. J. Am. Coll. Cardiol. 49(14):1566-1571; 2007.
88. Werner, N.; Junk, S.; Laufs, U.; Link, A.; Walenta, K.; Bohm, M.; Nickenig, G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res. 93(2):e17-e24; 2003.
89. Werner, N.; Kosiol, S.; Schiegl, T.; Ahlers, P.; Walenta, K.; Link, A.; Bohm, M.; Nickenig, G. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353(10):999-1007; 2005.
90. Wilson, D. W.; Lame, M. W.; Dunston, S. K.; Segall, H. J. DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cells. Toxicol. Appl. Pharmacol. 166(2):69-80; 2000.
91. Xia, L.; Fu, G. S.; Yang, J. X.; Zhang, F. R.; Wang, X. X. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: New insights into cell therapy for pulmonary arterial hypertension, Cytotherapy 11(4):492-502; 2009.
92. Xia, L.; Zhu, J. H.; Qiu, F. Y.; Yang, Y.; Xie, X. D.; Wang, X. X.; Chen, J. Z.; Fu, G. S. Senescent endothelial progenitor cells from dogs with pulmonary arterial hypertension: A before- after self-controlled study. J. Physiol. Sci. 59(6): 429-437; 2009.
93. Yang, J. X.; Tang, W. L.; Wang, X. X. Superparamagnetic iron oxide nanoparticles may affect endothelial progenitor cell migration ability and adhesion capacity. Cytotherapy 12(2):251-259; 2010.
94. +) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension. Am. J. Physiol. Lung Cell Mol. Physiol. 296(6): L870-L878; 2009.
95. Yip, H. K.; Chang, L. T.; Sun, C. K.; Sheu, J. J.; Chiang, C. H.; Youssef, A. A.; Lee, F. Y.; Wu, C. J.; Fu, M. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats. Crit. Care Med. 36(3):873- 880; 2008.
96. Zhao, Q.; Liu, Z.; Wang, Z.; Yang, C.; Liu, J.; Lu, J. Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension. Ann. Thorac. Surg. 84(2):544-552; 2007.
97. Zhao, Y. D.; Courtman, D. W.; Deng, Y.; Kugathasan, L.; Zhang, Q.; Stewart, D. J. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrowderived endothelial-like progenitor cells: Efficacy of combined cell and eNOS gene therapy in established disease. Circ. Res. 96(4):442-450; 2005.
98. Zhu, J. H.; Wang, X. X.; Zhang, F. R.; Shang, Y. P.; Tao, Q. M.; Chen, J. Z,Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: Open-label pilot study. Pediatr. Transplant. 12(6):650- 655; 2008.